Colleen Desiormaux
Director, Investor Relations
Replay available
Boralex Inc. (TSX: BLX) Q2 2025 earnings conference call, held 2025-08-08. Replay captured from the company's public earnings webcast.

Director, Investor Relations
President & Chief Executive Officer
Executive Vice President & Chief Financial Officer
Interim Chief Financial Officer
Analyst, TD Cowen
Analyst, RBC Capital Markets
Analyst, CIBC
Analyst, National Bank of Canada
Analyst, BMO Capital Markets
Analyst, Scotiabank
Good morning, ladies and gentlemen, and welcome to the Boralex Second Quarter 2025 Financial Results Conference Call. Note that all lines will be in listen-only mode. Following the presentation, we will conduct a question-and-answer session in which financial analysts, shareholders, and investors will be invited to ask their questions by pressing star 1 and 1 on the telephone and wait for their name to be announced. If you wish to ask a question via the webcast, please type them in the question box and click Submit. Please also note that today's conference is being recorded. For webcast participants, you can also ask questions during the conference, but they will be answered by email after the call. Finally, media representatives are invited to contact Camille Aventura, Senior Advisor, Public Affairs and External Communications at Boralex. Her contact information is provided at the end of the quarterly press release. I would now like to turn the conference over to Colleen Desiormaux, Director, Investor Relations for Boralex. Please go ahead. Thank you, operator. Good morning, everyone. Welcome to Boralex's second quarter results conference call. On today's call, Patrick Decote, our President and Chief Executive Officer, will provide an update of our business. Afterwards, Bruno Guillemette, our Executive Vice President and Chief Financial Officer, will present the financial highlights of the quarter. Then we will be available to answer your questions. During this call, we will discuss historical as well as forward-looking information. When talking about the future, there are a variety of risk factors that have been listed in our different filings, which can materially change our estimated results. These documents are all available for consultation on CDAR. Mr. Ducasse...